WHO Joint Advisory Group on COVID 19 Therapeutics Prioritization - DRAFT Statement on the possible effects of the new SARS CoV-2 Omicron variant on treatment of hospitalized COVID-19 patients

Overview

On 1 December 2021, WHO convened its Joint Advisory Group on COVID 19 Therapeutics Prioritization to perform a preliminary review and analysis of the potential impact of the SARS CoV-2 Omicron variant on drugs against COVID-19, either in use or under investigation.